Articles

May 29, 2020

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.

Click below to access the full chapter.

See file

Back

Last related news

November 17, 2023

Article “How to patent biological materials from 3D printing” for LSIPR

The article “How to patent biological materials from 3D printing,” written by our partner Priscila Kashiwabara and patent specialist Breno Souza, has … Article “How to patent biological materials from 3D printing” for LSIPR

October 11, 2023

Lexology GTDT – Pharma & Medical Device Regulation 2024

The chapter “Pharma & Medical Device Regulation,” authored by our partners Claudio Barbosa, Viviane Trojan and attorney at law Giovanna Mezher, has … Lexology GTDT – Pharma & Medical Device Regulation 2024

September 14, 2023

On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”, published on IAM Media, authored by … On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil